Controlled release morphine preparation

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 5520931
SERIAL NO

08362526

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention concerns an oral morphine preparation having essentially complete bioavailability and, for the major part of the dissolution, an essentially zero order and essentially pH independent release of morphine for a period of at least 8 hours, preferably at least 12 hours, during which a period less than 100% is dissolved. In the preparation, the morphine, in the form of an easily soluble salt, is present in a combination with a buffering agent in a preparation coated with a diffusion membrane.

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
GACELL LABORATORIES ABLUNDAVAGEN 151 24 MALMO S-212

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Frigren, Lennart Hollviken, SE 1 81
Kulstad, Soren Rydeback, SE 2 167
Persson, Christiane Bjarred, SE 1 81
Waxegard, Staffan Malmo, SE 1 81

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation